Venture Capital Fundraising Rebounds In Q1 As Mega-Rounds Dominate
Number Of Firms Financed Fell From A Year Ago
Biopharma firms raised $6bn in the first quarter of 2024, the most of any quarter since Q2 2022. But without an increase in the number of companies raising funds, the rebound remains uneven.
